Alexis Williams
Psychiatric/Mental Health · Houston, TXNPI 1831561901
Payments from drug & device makers
Across 509 payments — averaging $23.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Axsome Therapeutics, Inc.$893
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$745
- Neurocrine Biosciences, Inc.$718
- Bausch Health US, LLC$664
- plus $6K from 29 others
What the payments were for
- Food & beverage$11,76999%
- Education$1141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 63 | $1,269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 53 | $1,139 |
| Axsome Therapeutics, Inc. | 24 | $893 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $745 |
| Neurocrine Biosciences, Inc. | 34 | $718 |
| Bausch Health US, LLC | 41 | $664 |
| Johnson & Johnson | 16 | $624 |
| Supernus Pharmaceuticals, Inc. | 21 | $617 |
| Teva Pharmaceuticals USA, Inc. | 27 | $588 |
| Sunovion Pharmaceuticals Inc. | 28 | $572 |
| Corium, LLC | 17 | $451 |
| AbbVie | 22 | $418 |
| Alkermes, Inc. | 17 | $361 |
| Lundbeck LLC | 16 | $348 |
| Tris Pharma Inc | 3 | $345 |
| Vanda Pharmaceuticals Inc. | 13 | $343 |
| Neos Therapeutics, LP | 16 | $284 |
| Almatica Pharma LLC | 14 | $264 |
| Ironshore Pharmaceuticals Inc. | 10 | $252 |
| Harmony Biosciences LLC | 7 | $179 |
| Jazz Pharmaceuticals Inc. | 7 | $160 |
| Noven Therapeutics, LLC | 5 | $100 |
| Validus Pharmaceuticals LLC | 4 | $83 |
| Idorsia Pharmaceuticals US Inc | 3 | $72 |
| Arbor Pharmaceuticals, Inc. | 4 | $59 |
| Merck | 4 | $57 |
| MML US, Inc. | 1 | $52 |
| Eisai Inc. | 3 | $49 |
| Nevro Corp. | 1 | $38 |
| Avanir Pharmaceuticals, Inc. | 2 | $33 |
| Vertical Pharmaceuticals, LLC | 2 | $31 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Medline Industries LP | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$355
- QELBREE$290
- Dyanavel XR$250
- Quillivant$250
- Quillichew ER$250
- INVEGA$150
- Fanapt$125
- ABILIFY MAINTENA$123
- ABILIFY ASIMTUFII$123
- CAPLYTA$122
- INVEGA SUSTENNA$115
- Azstarys$114
How this compares
$11,882 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 13 | $9,011 |
| Bupropion XlBupropion Hcl | 59 | $1,980 |
| Clonazepam | 94 | $708 |
| Alprazolam | 80 | $542 |
| Duloxetine Hcl | 34 | $517 |
| Zolpidem Tartrate | 53 | $454 |
| Lamotrigine | 27 | $301 |
| Zaleplon | 16 | $278 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $251 |
| Escitalopram Oxalate | 20 | $177 |
| Lorazepam | 27 | $154 |
| Fluoxetine Hcl | 28 | $105 |
| Quetiapine Fumarate | 14 | $89 |
| Paroxetine Hcl | 12 | $69 |
| Gabapentin | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $1,139 | $9,01113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Houston
- Natalie TellezHouston$602K
- Britney PridgenHouston$57K
- Linzi LeightonHouston$16K
- Samantha SharpeHouston$14K
- Jennifer RobinsonHouston$12K
- Tracy HicksLongview$684K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.